Rob Stein
Rob Stein is a correspondent and senior editor on NPR's science desk.
An award-winning science journalist with more than 30 years of experience, Stein mostly covers health and medicine. He tends to focus on stories that illustrate the intersection of science, health, politics, social trends, ethics, and federal science policy. He tracks genetics, stem cells, cancer research, women's health issues, and other science, medical, and health policy news.
Before NPR, Stein worked at The Washington Post for 16 years, first as the newspaper's science editor and then as a national health reporter. Earlier in his career, Stein spent about four years as an editor at NPR's science desk. Before that, he was a science reporter for United Press International (UPI) in Boston and the science editor of the international wire service in Washington.
Stein's work has been honored by many organizations, including the National Academy of Sciences, the American Association for the Advancement of Science, the American Association for Cancer Research, and the Association of Health Care Journalists. He was twice part of NPR teams that won Peabody Awards.
Stein frequently represents NPR, speaking at universities, international meetings and other venues, including the University of Cambridge in Britain, the World Conference of Science Journalists in South Korea, and the Aspen Institute in Washington, DC.
Stein is a graduate of the University of Massachusetts, Amherst. He completed a journalism fellowship at the Harvard School of Public Health, a program in science and religion at the University of Cambridge, and a summer science writer's workshop at the Marine Biological Laboratory in Woods Hole, Mass.
-
More and more cases are being diagnosed in this country. And those numbers may grow as testing for this dangerous new virus ramps up.
-
A problem with one ingredient in test kits that the Centers for Disease Control and Prevention distributed to labs around the U.S. had created a frustrating bottleneck.
-
During a news conference, the president struck a reassuring tone — saying it's not inevitable the virus will spread in the U.S. That's despite warnings to the contrary from public health officials.
-
The Centers for Disease Control and Prevention is urging Americans to prepare for the possibility of more aggressive measures to stop the new coronavirus in the United States.
-
A New Orleans law professor and a New Jersey financial analyst are waiting for their stints in the first federal quarantine in a half-century to end. Here's glimpse of their daily lives.
-
A temporary ban prevents anyone from China from entering the U.S., and Americans who may have been exposed to the coronavirus are subject to quarantine. Experts differ in their views on the policies.
-
Health officials announced that a second person in the United States is infected with the dangerous new coronavirus and that 50 more possible cases in the U.S. are under investigation.
-
Aiming to find a cheaper, easier way than IVF to ensure human embryos are healthy before implantation, researchers paid women to be inseminated, then flushed the embryos from their wombs for analysis.
-
Chinese scientist He Jiankui has been sentenced to three years in prison for conducting gene-editing experiments on human embryos.
-
NPR tells the exclusive, behind-the-scenes story of the first person with a genetic disorder to be treated in the United States with the revolutionary gene-editing technique CRISPR.
-
Scientists are reporting the first evidence that genetically edited cells could be safely helping a patient with sickle cell disease. The cells are producing a crucial oxygen-carrying protein.
-
Researchers edited the DNA in bone marrow cells taken from a Mississippi woman with sickle cell disease to produce a treatment that could alleviate the excruciating effects of her inherited illness.